Articles
Pharmalicensing brings you advice, commentary and analysis from industry experts.
- Articles
- Browse
Articles
ESBATech is drug discovery company, exploiting its expertise in yeast technology for the development of therapeutic antibody fragments and the development of functional assays for small molecule screenings More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 8 pages - $75
Nov 2011 - 8 pages - $75
Jan 2006 - 21 pages - $1,100
May 2011 - 3 pages - $100
Feb 2011 - 15 pages - $125
May 2010 - 8 pages - $395
Your selection
- Industry sector
- Research tools del
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us